Home >> MARKETPLACE >> Ortho launches MicroTip Partnership assays

Ortho launches MicroTip Partnership assays

Print Friendly, PDF & Email

January 2019—Ortho Clinical Diagnostics is offering three new assays through its MicroTip Partnership Assay program. The company will offer kappa free light chain and lambda free light chain assays in collaboration with Diazyme Laboratories and a methotrexate assay through a collaboration with Ark Diagnostics and Sekisui Diagnostics.

The assays have been validated for use on Ortho’s Vitros 5600 Integrated System and Vitros 4600 Chemistry System. Kappa free light chain and lambda free light chain assays will be available in the U.S., Europe, the Middle East, and Africa, and the methotrexate assay will be available in the U.S.

Ortho Clinical Diagnostics, 800-421-3311

x

Check Also

FDA clears Ortho’s Vitros XT 7600 Integrated System

Nov. 5, 2018—Ortho Clinical Diagnostics received FDA clearance for its Vitros XT 7600 Integrated System....

X